Article
Amid two seemingly unrelated trends, the rise of high-deductible health plans and the growing prevalence and burden of chronic diseases, it may time to rethink the concept and regulation of preventive services, argue advocates of value-based insurance.
Amid two seemingly unrelated trends, the rise of high-deductible health plans and the growing prevalence and burden of chronic diseases, it may time to rethink the concept and regulation of preventive services, argue advocates of value-based insurance.
Any of the 18 million Americans diagnosed with diabetes and enrolled in a high-deductible health plan with a health savings account has to pay for glucose, blood pressure, cholesterol and eye tests, among other necessities, out-of-pocket before hitting their deductible, as dictated by Internal Revenue Service regulations for HSA-eligible plans.
Depending on a person’s income, that can be a disincentive to get a test or take a medication in the short-run, but in the long-run potentially lead to avoidable complications and unnecessary spending.
Read the full story here: http://bit.ly/1guYmN1
Source: Healthcare Payer News